A postmortem study of amino acid neurotransmitters in Alzheimer's disease
- PMID: 2878639
- DOI: 10.1002/ana.410200510
A postmortem study of amino acid neurotransmitters in Alzheimer's disease
Abstract
Concentrations of putative neurotransmitter amino acids were measured in postmortem brains from 10 patients with Alzheimer's disease and 10 controls. Glutamate, aspartate, taurine, gamma-aminobutyric acid (GABA), and alanine levels were examined in 9 cortical regions, hippocampus, thalamus, and basal ganglia using high-performance liquid chromatography with electrochemical detection. There were no significant alterations in aspartate, taurine, or alanine levels in any of the regions examined. Widespread significant reductions in cortical GABA concentrations were observed in the Alzheimer's brains, with the largest decreases in the temporal lobe. Overall values for glutamate concentrations in temporal and frontal cortices showed a significant 12% reduction in Alzheimer's brains, but the only individual cortical region showing a significant reduction in glutamate was the inferior temporal gyrus. These results suggest that gamma-aminobutyric acidergic neurons in Alzheimer's cerebral cortex may be selectively vulnerable to the disease process.
Similar articles
-
Regional distribution of amino acid transmitters in postmortem brains of presenile and senile dementia of Alzheimer type.Ann Neurol. 1986 Mar;19(3):263-9. doi: 10.1002/ana.410190307. Ann Neurol. 1986. PMID: 2870679
-
Amino acid neurotransmitters in postmortem human brain analyzed by high performance liquid chromatography with electrochemical detection.J Neurosci Methods. 1987 Apr;19(4):305-15. doi: 10.1016/0165-0270(87)90073-2. J Neurosci Methods. 1987. PMID: 2884352
-
Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease.Ann Neurol. 1987 Apr;21(4):331-6. doi: 10.1002/ana.410210403. Ann Neurol. 1987. PMID: 3579218
-
Cortical amino acidergic pathways in Alzheimer's disease.J Neural Transm Suppl. 1987;24:147-52. J Neural Transm Suppl. 1987. PMID: 2824688 Review.
-
Inhibitory neuromodulation of release of amino acid neurotransmitters.Alcohol Drug Res. 1985-1986;6(4):253-64. Alcohol Drug Res. 1985. PMID: 2868735 Review.
Cited by
-
Towards a Better Understanding of GABAergic Remodeling in Alzheimer's Disease.Int J Mol Sci. 2017 Aug 21;18(8):1813. doi: 10.3390/ijms18081813. Int J Mol Sci. 2017. PMID: 28825683 Free PMC article. Review.
-
GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer's disease.Semin Cell Dev Biol. 2021 Aug;116:146-159. doi: 10.1016/j.semcdb.2021.01.005. Epub 2021 Feb 9. Semin Cell Dev Biol. 2021. PMID: 33573856 Free PMC article. Review.
-
Impaired Expression of GABA Signaling Components in the Alzheimer's Disease Middle Temporal Gyrus.Int J Mol Sci. 2020 Nov 18;21(22):8704. doi: 10.3390/ijms21228704. Int J Mol Sci. 2020. PMID: 33218044 Free PMC article.
-
Aberrant Expression of GABA-Related Genes in the Hippocampus of 3xTg-AD Model Mice from the Early to End Stages of Alzheimer's Disease.J Alzheimers Dis. 2023;94(1):177-188. doi: 10.3233/JAD-230078. J Alzheimers Dis. 2023. PMID: 37212113 Free PMC article.
-
Hippocampal plasticity during the progression of Alzheimer's disease.Neuroscience. 2015 Nov 19;309:51-67. doi: 10.1016/j.neuroscience.2015.03.006. Epub 2015 Mar 12. Neuroscience. 2015. PMID: 25772787 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical